Archive: 2024
EHA-ECL led statement calls for protection of the Hospital Exemption
![EUR Affairs Hospital Exemption 1920 x 1080 px 1](/assets/Uploads/EUR-Affairs-Hospital-Exemption-1920-x-1080-px-1__ScaleMaxWidthWzY0MF0.png)
The hospital exemption (HE) is a vital provision within the EU's pharmaceutical legislation, currently subject to a revision.
Urgent action needed to avoid widespread shortage of in-vitro diagnostic tests
![AdobeStock 135134857](/assets/Uploads/AdobeStock_135134857__ScaleMaxWidthWzY0MF0.jpeg)
In a new statement, BioMed Alliance highlights its increasing concern about the availability of In Vitro Diagnostic (IVD) testing devices in Europe.
Helping to shape Europe’s clinical trials landscape: EHA selected for ACT EU adv…
![EHA joins ACT EU advisory board image](/assets/Uploads/EHA-joins-ACT-EU-advisory-board-image__ScaleMaxWidthWzY0MF0.png)
Improving the design, efficiency and effectiveness of clinical trials is the objective of the Accelerating Clinical Trials in the European Union (ACT EU) initiative.